Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Oesophageal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03110926
What this trial is testing

Induction Chemotherapy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
University of Rochester 40
Large-scale testing (Phase 3)UnknownNCT01216527
What this trial is testing

Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer

Who this might be right for
Squamous Cell Esophageal Carcinoma
Sun Yat-sen University 430
Testing effectiveness (Phase 2)UnknownNCT02812641
What this trial is testing

Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

Who this might be right for
Stage III Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07554521
What this trial is testing

Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

Who this might be right for
Advanced Unresectable Gastric AdenocarcinomaEsophageal Squamous Cell CarcinomaAdvanced Gastroesophageal Adenocarcinoma
BeOne Medicines 30
Early research (Phase 1)Not Yet RecruitingNCT07726212
What this trial is testing

A First-in-human (FIH), Open-Label, Dose Escalation and Expansion Cohorts Study of MC002

Who this might be right for
Advanced Esophageal CancerAdvanced Lung Cancer
Hangzhou MacroLink Biopharmaceutical LLC 143
Testing effectiveness (Phase 2)Study completedNCT00016900
What this trial is testing

PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT05302011
What this trial is testing

Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 28
Large-scale testing (Phase 3)UnknownNCT03958890
What this trial is testing

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Henlius Biotech 489
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Large-scale testing (Phase 3)Study completedNCT00416858
What this trial is testing

Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 40
Testing effectiveness (Phase 2)Ended earlyNCT03278626
What this trial is testing

Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
NYU Langone Health 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT06914011
What this trial is testing

Circulating Tumor DNA MRD-Guided Adjuvant Therapy for Curatively Resected Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Asan Medical Center 172
Early research (Phase 1)Study completedNCT00921739
What this trial is testing

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung CancerThymoma+1 more
Duke University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770672
What this trial is testing

An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging

Who this might be right for
Esophageal CancerESCC
Tan Lijie 92
Not applicableLooking for participantsNCT05740995
What this trial is testing

Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Chemoimmunotherapy
Shanghai Zhongshan Hospital 40
Testing effectiveness (Phase 2)UnknownNCT06403878
What this trial is testing

Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Sichuan University 68
Testing effectiveness (Phase 2)Study completedNCT00005599
What this trial is testing

Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Testing effectiveness (Phase 2)Looking for participantsNCT06510660
What this trial is testing

Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaImmunotherapyBiomarkers
Fujian Medical University Union Hospital 48
Next Page